CoChat

Antibiotic-Free Selection in Biotherapeutics: Now and Forever

Open access

The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.

Abstract

The continuously improving sophistication of molecular engineering techniques gives access to novel classes of bio-therapeutics and new challenges for their production in full respect of the strengthening regulations. Among these biologic agents are DNA based vaccines or gene therapy products and to a lesser extent genetically engineered live vaccines or delivery vehicles. The use of antibiotic-based selection, frequently associated with genetic manipulation of microorganism is currently undergoing a profound metamorphosis with the implementation and diversification of alternative selection means. This short review will present examples of alternatives to antibiotic selection and their context of application to highlight their ineluctable invasion of the bio-therapeutic world.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/pathogens4020157

Cites

110 of 110 references verified0 citation errors · 0 not checkable

Statistics

Figures

Scheme 1 Plasmid selection and maintenance by auxotrophy complementation. (A): Strain auxotrophy is due to an essential gene mutation or deletion. The auxotrophy is complemented by the plasmid-born expression of the functional gene. (B): Strain auxotrophy is due to an amber mutation in an essential gene. Expression of the suppressor tRNA correcting amber mutation can complement the auxotrophy. GoI: Gene of Interest; ori: Origin of replication.
Scheme 1 Plasmid selection and maintenance by auxotrophy complementation. (A): Strain auxotrophy is due to an essential gene mutation or deletion. The auxotrophy is complemented by the plasmid-born expression of the functional gene. (B): Strain auxotrophy is due to an amber mutation in an essential gene. Expression of the suppressor tRNA correcting amber mutation can complement the auxotrophy. GoI: Gene of Interest; ori: Origin of replication.CC BY · PubMed Central
Scheme 2 Plasmid selection and maintenance by Operator Repressor Titration. Note of a: An essential gene is repressed by a genome encoded repressor. Plasmid containing several sequences of the operator can titrate this repressor by competition, allowing essential gene expression. GoI: Gene of Interest; ori: Origin of replication.
Scheme 2 Plasmid selection and maintenance by Operator Repressor Titration. Note of a: An essential gene is repressed by a genome encoded repressor. Plasmid containing several sequences of the operator can titrate this repressor by competition, allowing essential gene expression. GoI: Gene of Interest; ori: Origin of replication.CC BY · PubMed Central
Scheme 3 Plasmid selection or/and maintenance by post-segregational killing. (A): Both toxin and antitoxin genes are on the plasmid allowing plasmid maintenance. Another marker (i.e., antibiotic resistant gene) is still needed to allow strain selection. (B): As the toxin gene is inserted into bacterial genome and antitoxin is plasmid-born, this system allows both selection and plasmid maintenance in absence of any antibiotic. GoI: Gene of Interest; ori: Origin of replication.
Scheme 3 Plasmid selection or/and maintenance by post-segregational killing. (A): Both toxin and antitoxin genes are on the plasmid allowing plasmid maintenance. Another marker (i.e., antibiotic resistant gene) is still needed to allow strain selection. (B): As the toxin gene is inserted into bacterial genome and antitoxin is plasmid-born, this system allows both selection and plasmid maintenance in absence of any antibiotic. GoI: Gene of Interest; ori: Origin of replication.CC BY · PubMed Central
Scheme 4 Plasmid selection and maintenance by RNA/RNA interaction. (A): An essential gene is under control of a repressor fused to RNAI homologous sequence. RNAI, produced from plasmid ori (ColE1 derived), binds to this homologous RNA, inhibits the repressor translation and restores the essential gene expression. (B): sacB gene is inserted into the genome, fused to RNA-IN sequence. RNA-OUT, encoded by the plasmid, binds to RNA-IN, inhibiting sacB translation, restoring ability of the strain to grow on sucrose containing medium. GoI: Gene of Interest; ori: Origin of replication.
Scheme 4 Plasmid selection and maintenance by RNA/RNA interaction. (A): An essential gene is under control of a repressor fused to RNAI homologous sequence. RNAI, produced from plasmid ori (ColE1 derived), binds to this homologous RNA, inhibits the repressor translation and restores the essential gene expression. (B): sacB gene is inserted into the genome, fused to RNA-IN sequence. RNA-OUT, encoded by the plasmid, binds to RNA-IN, inhibiting sacB translation, restoring ability of the strain to grow on sucrose containing medium. GoI: Gene of Interest; ori: Origin of replication.CC BY · PubMed Central
Scheme 5 Plasmid-free expression after genomic integration. The gene of interest (GoI) is inserted into the genome to avoid antibiotic resistance gene in the production strain.
Scheme 5 Plasmid-free expression after genomic integration. The gene of interest (GoI) is inserted into the genome to avoid antibiotic resistance gene in the production strain.CC BY · PubMed Central
Scheme 6 Minicircle production. The producer plasmid is selected using an antibiotic resistance gene. Cleavage and recombination leads to the formation of circular plasmid backbones and minicircles. Minicircles do not contain any antibiotic resistance gene. Strategies of in vivo degradation of plasmid backbone are developed to facilitate minicircle purification.
Scheme 6 Minicircle production. The producer plasmid is selected using an antibiotic resistance gene. Cleavage and recombination leads to the formation of circular plasmid backbones and minicircles. Minicircles do not contain any antibiotic resistance gene. Strategies of in vivo degradation of plasmid backbone are developed to facilitate minicircle purification.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 110 references

Research works printed but not linked: 1

  1. WHO (2005, January 24–28). Guidelines for assuring the quality of non clinical safety evaluation of DNA vaccines. Proceedings of the 56th Meeting of the WHO Expert Committee on Biological Standardization, Geneva, Switzerland.

Cited by

See all 89

Metadata

Authors
Mignon, C., Sodoyer, R., & Werle, B.
Affiliations
BIOASTER (FR)
Corresponding author
Sodoyer, Régis
Venue
Pathogens
Publisher
MDPI AG
Published
2015-04-03
Volume
4
Issue
2
Pages
157-181
ISSN
2076-0817 (ISSN-L)
OpenAlex
W2057140623
Cited by
87
References
110
Citations by year
2026: 10 · 2025: 5 · 2024: 9 · 2023: 6 · 2022: 14 · 2021: 12 · 2020: 7 · 2019: 7 · 2018: 7 · 2017: 3 · 2016: 5 · 2015: 2
FWCI
0.72
Type
journal article
Language
en
Open access
Locations
  • Pathogens (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Microbial Metabolic Engineering and Bioproduction
Keywords
antibiotic-free selection, biopharmaceutical manufacturing, DNA vaccine, gene therapy products, delivery vehicles, molecular engineering

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antibiotic-Free Selection in Biotherapeutics: Now and Forever. https://app.cochat.ai/papers/10.3390/pathogens4020157
The paper
Mignon, C., Sodoyer, R., & Werle, B. (2015). Antibiotic-Free Selection in Biotherapeutics: Now and Forever. Pathogens. https://doi.org/10.3390/pathogens4020157

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.